TABLE 1

Demographic and Clinical Data of All Study Participants

Patient no.	Age (y)	Sex	Weight (kg)	Disease	Injected ¹⁸F-FDG dose (MBq)	Interval (min)^*
1	40	F	73	Ovarian cancer	230	28
2	69	M	90	Colon cancer	270	40
3	79	M	90	Lung cancer	305	38
4	49	M	97.5	Lung cancer	305	40
5	36	M	79.5	Sarcoidosis	220	42
6	84	M	91	Lung cancer	270	42
7	66	F	101	Thyroid cancer	300	29
8	75	M	88.2	Multiple myeloma	280	60
9	66	F	72	Breast cancer	215	32
10	74	M	139	Melanoma	405	33
11	59	M	106	Esophageal cancer	305	30
12	84	M	73	Esophageal cancer	220	33
13	59	M	104	Oropharyngeal cancer	320	37
14	77	M	62	Colon cancer	200	39
15	62	M	77	Esophageal cancer	240	46
16	63	M	105	Lymphoma	300	41
17	52	F	115	Lymphoma	355	36
18	60	F	89	Esophageal cancer	235	35
19	47	F	53	Lung cancer	145	36
20	25	M	79	Testicular cancer	235	24

↵* Interval between first and second scans. Images were acquired on Biograph mCT first for the first 10 patients. For the other 10 patients, images were acquired on Biograph Vision first.